By increasing the availability of MSK-ACCESS® powered with SOPHiA DDM™, SOPHiA GENETICS and AstraZeneca aim to understand further how liquid biopsy testing can complement solid tissue testing ...

"Our collaboration with AstraZeneca represents a significant step toward scaling next-generation oncology diagnostics ...

(RTTNews) - SOPHiA GENETICS SA (SOPH), Monday announced the expansion of its global partnership with AstraZeneca PLC (AZN) to accelerate the worldwide deployment of MSK-ACCESS powered with SOPHiA ...

SOPHiA GENETICS, known for its cloud-native healthcare technology, continues its mission to democratize data-driven medicine through its AI-powered SOPHiA DDM™ Platform, supporting cancer and rare ...

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and global leader in data-driven medicine, today ...